Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
1999 R43 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete
2001 R43 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS Complete
2004 R43 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2003 R43 PAR-01-105 SHEN, LI SUPERARRAY BIOSCIENCE CORPORATION ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT Complete
2000 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2002 R43 PAR-01-105 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. RAPID MOLECULAR DETECTION OF PML/RARALPHA Complete
1999 R43 PAR-98-066 XANTHOPOULOS, KLEANTHIS G AURORA BIOSCIENCES CORPORATION ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS Complete
2001 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2004 R43 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2003 R43 PAR-01-105 DIATCHENKO, LUDA ATTAGENE, INC. PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER Complete
2009 R43 RFA-CA-08-011 ZWICK, MICHAEL G ANDROBIOSYS, INC. PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU Complete
2000 R43 PAR-98-066 BOGEN, STEVEN A CYTOLOGIX CORPORATION INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS Complete
2002 R43 PAR-01-105 YANG, XING GENEOHM SCIENCES, INC. MULTIPLEXED DNA-MEDIATED ELECTOCHEMICAL SENSORS Complete
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. GENE EXPRESSION ANALYSIS ON RANDOMLY ORDERED DNA ARRAYS Complete
2003 R43 PAR-01-105 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC PROTEIN ARRAYS FOR MOLECULAR ANALYSIS OF CANCER TISSUE Complete
2009 R43 RFA-CA-08-011 RUIZ, JOSEPH C TRANSPOSAGEN BIOPHARMACEUTICALS, INC. TISSUE-SPECIFIC MUTAGENESIS IN RAT AS AN IN VIVO TOOL FOR COLON CANCER GENE DISCO Complete
2000 R43 PAR-99-101 GOLOVLEV, VAL V SCI-TEC, INC. MAGNETIC DISK ARRAY DNA ANALYZER Complete
2002 R43 PAR-01-105 HANCOCK, LAWRENCE F NOMADICS, INC. POLYMER AMPLIFIED NUCLEIC ACID DETECTION Complete
1999 R43 PAR-98-066 HAGEN, FREDERICK S ICOGENEX CORPORATION AFFINITY AND TRANSCRIPTASE TECHNOLOGIES Complete
2003 R43 PAR-01-105 SCHNEIDER, LUKE V TARGET DISCOVERY IDBEST DIFFERENTIAL DISPLAY ON PROTEIN CHIPS Complete
2000 R43 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. PHARMACOGENOMICS OF CARCINOGENESIS IN WHOLE ANIMALS Complete
2002 R43 PAR-01-105 YANG, CHIHAE LEADSCOPE, INC. A NOVEL CHEMICAL GENOMICS METHODOLOGY Complete
1999 R43 PAR-98-066 GERDES, JOHN CHARLES XTRANA, INC. QUANTITATION AND ARCHIVING OF GENE EXPRESSION Complete
2007 R43 RFA-CA-07-010 BOGEN, STEVEN A MEDICAL DISCOVERY PARTNERS, LLC ISOLATION OF CIRCULATING TUMOR CELLS FROM PERIPHERAL BLOOD Complete
2003 R43 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. ITP-BASED SELECTIVE ENRICHMENT OF LOW ABUNDANCE PROTEINS Complete
2000 R43 PAR-99-101 MOEN, PHILLIP T ONE CELL SYSTEMS, INC NOVEL METHOD FOR DETECTING NON-HODGKIN'S LYMPHOMA Complete
2002 R43 PAR-01-105 TRNOVSKY, JAN ONE CELL SYSTEMS, INC METHOD FOR DETECTING CHRONIC MYELOGENOUS LEUKEMIA CELLS Complete
1999 R43 PAR-98-066 BITTER, GRANT A. BITTECH, INC. DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS Complete
2007 R43 RFA-CA-07-008 GORDON, NEAL FRANCIS EPITOME BIOSYSTEMS, INC A STANDARDIZED ANTIBODY MICROARRAY-BASED SYSTEM FOR THE QUANTITATIVE MEASUREMENT Complete
2020 R43 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Complete
2000 R43 PAR-99-101 SERBEDZIJA, GEORGE N PHYLONIX PHARMACEUTICALS, INC. WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING Complete
2002 R43 PAR-01-105 LATHAM, GARY J AMBION, INC. ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA Complete
1999 R43 PAR-98-066 MONFORTE, JOSEPH A GENETRACE SYSTEMS, INC. EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS Complete
2007 R43 RFA-CA-07-008 MEDGHALCHI, SUSAN FASGEN, INC. FATTY ACID SYNTHASE PHOSPHORYLATION AS A CANCER BIOMARKER Complete
2014 R43 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY Complete
2000 R43 PAR-99-101 KOGON, ALEX A BIOLINX, LLC THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING Complete
2002 R43 PAR-01-105 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER Complete
1999 R43 PAR-98-066 RICHTERICH, PETER CODONCODE CORPORATION SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION Complete
2007 R43 RFA-CA-07-010 KRAVITZ, RACHEL HANNAH NEOCLONE BIOTECHNOLOGY INTERNATIONAL A NOVEL PLATFORM FOR MINING THE REPERTOIRE OF ANTIGEN-SPECIFIC B CELLS Complete
2014 R43 PAR-13-327 FELLMANN, CHRISTOF MIRIMUS, INC. RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO Complete
2000 R43 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2018 R43 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues Active
1999 R43 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2017 R43 PAR-13-327 PEYTAVI, REGIS BLUENOVO BIOSYSTEMS, INC. Detection of Methylation and Translocation Events by Novel Sequencing Technology Complete
2000 R43 PAR-99-101 RENARD, ANDRE INTERGEN COMPANY PYRENE-CONTAINING PROBES FOR MUTATION DETECTION Complete
2002 R43 PAR-01-105 MC GARRITY, GERARD J. INTRONN, INC. PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER Complete
2018 R43 PAR-18-303 LEE, LY JAMES NANOMATERIAL INNOVATION, LTD Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis Complete
1999 R43 PAR-98-066 CRONIN, MAUREEN T. PROTOGENE LABORATORIES, INC. DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD Complete
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active

Pages